Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

NCT03057054

Conditions
Acute Graft Versus Host Disease, Hematologic Diseases, Hematopoietic and Lymphatic System Neoplasm, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

NCT05556720

Conditions
Blood Protein Disorders, COVID-19 Vaccines, Cardiovascular Diseases, +27 more
Locations
  • St Vincents Hospital Darlinghurst, New South Wales, Australia
  • Prince Of Wales Hospital Randwick, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Womens Hospital Herston, Queensland, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

NCT05878184

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

NCT05911763

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Banner MD Anderson Cancer Center- Site Number : 8400008 Gilbert, Arizona, United States
  • Loma Linda University- Site Number : 8400015 Loma Linda, California, United States
  • Orthopedic Institute for Children- Site Number : 8400004 Los Angeles, California, United States
  • The Center for Inherited Blood Disorders- Site Number : 8400001 Orange, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

NCT04229979

Conditions
Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations
  • O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Colorado Blood Cancer Institute - SCRI - PPDS Denver, Colorado, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.

NCT05181592

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Universitätsklinikum Leipzig Leipzig, Germany
  • Klinikum rechts der Isar München, Germany
View all 13 locations
View Trial Details

Related conditions